<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8"/>
  <meta name="viewport" content="width=device-width, initial-scale=1"/>
  <title>Results ‚Äî Personality √ó Drug Use</title>
  <meta name="description" content="Statistical findings, drug-group comparisons, personality effects, and chi-square/ANOVA/correlation results." />
  <link rel="stylesheet" href="style.css?v=1"/>

  <style>
    /* Mini summary tables */
    table.mini-table {
      width: 100%;
      max-width: 480px;
      margin: 12px 0 18px 0;
      border-collapse: collapse;
      background: rgba(255,255,255,0.55);
      backdrop-filter: blur(6px);
      box-shadow: 0 4px 14px rgba(0,0,0,0.12);
      border-radius: 8px;
      overflow: hidden;
    }
    table.mini-table th {
      background: rgba(240,240,240,0.9);
      padding: 8px;
      font-weight: bold;
      text-align: left;
    }
    table.mini-table td {
      padding: 7px 10px;
      border-bottom: 1px solid #ddd;
    }
    table.mini-table tr:last-child td {
      border-bottom: none;
    }

    img.plot {
      max-width: 100%;
      border-radius: 12px;
      box-shadow: 0 6px 18px rgba(0,0,0,0.18);
      margin-top: 10px;
      margin-bottom: 12px;
    }
  </style>
</head>

<body>

<header class="site-header">
  <a class="brand" href="./">
    <span class="brand-mark">üß™</span>
    <span class="brand-text">Personality √ó Drug Use</span>
  </a>
  <nav class="nav inline">
    <a href="proposal.html">Proposal</a>
    <a href="dataset.html">Dataset</a>
    <a href="visualization.html">Visualizations</a>
    <a href="results.html" aria-current="page">Results</a>
  </nav>
</header>

</section>

<!-- ===================== -->
<!-- SUMMARY OF ANALYSES -->
<!-- ===================== -->
<section class="glass pad">
  <h2>Summary of Analyses</h2>

<!-- ===================== -->
<!-- CANNABIS -->
<!-- ===================== -->
<details open>
<summary><strong>Cannabis</strong></summary>

<h4>Chi-square Tests</h4>
<table class="mini-table">
<tr><th>Comparison</th><th>Statistic</th></tr>
<tr><td>Education √ó Use</td><td>X¬≤ = 112.08, p &lt; 2.2e-16</td></tr>
<tr><td>Country √ó Use</td><td>X¬≤ = 241.94, p &lt; 2.2e-16</td></tr>
</table>

<h4>ANOVA (User vs Non-User)</h4>
<table class="mini-table">
<tr><th>Trait</th><th>Effect</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>Higher</td><td>1.8e-05</td></tr>
<tr><td>Extraversion</td><td>Lower</td><td>0.029</td></tr>
<tr><td>Openness</td><td>Much higher</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>Lower</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>Lower</td><td>&lt;1e-7</td></tr>
</table>

<h4>Correlations With Frequency</h4>
<table class="mini-table">
<tr><th>Trait</th><th>r</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>0.095</td><td>4.0e-05</td></tr>
<tr><td>Extraversion</td><td>-0.016</td><td>0.483</td></tr>
<tr><td>Openness</td><td>0.412</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>-0.150</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>-0.276</td><td>&lt;1e-7</td></tr>
</table>

<p>Cannabis use varies sharply across both education and country, with highest use among university-educated respondents and those from the USA/UK. Cannabis users consistently show high Openness and low Conscientiousness and Agreeableness; frequency of use reinforces this same trait pattern.</p>
</details>

<!-- ===================== -->
<!-- NICOTINE -->
<!-- ===================== -->
<details>
<summary><strong>Nicotine</strong></summary>

<h4>Chi-square Tests</h4>
<table class="mini-table">
<tr><th>Comparison</th><th>Statistic</th></tr>
<tr><td>Education √ó Use</td><td>X¬≤ = 67.48, p = 1.55e-11</td></tr>
<tr><td>Country √ó Use</td><td>X¬≤ = 86.67, p &lt; 2.2e-16</td></tr>
</table>

<h4>ANOVA</h4>
<table class="mini-table">
<tr><th>Trait</th><th>Effect</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>Higher</td><td>8e-05</td></tr>
<tr><td>Extraversion</td><td>No effect</td><td>0.150</td></tr>
<tr><td>Openness</td><td>Higher</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>Lower</td><td>1e-6</td></tr>
<tr><td>Conscientiousness</td><td>Lower</td><td>&lt;1e-7</td></tr>
</table>

<h4>Correlations</h4>
<table class="mini-table">
<tr><th>Trait</th><th>r</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>0.127</td><td>&lt;1e-7</td></tr>
<tr><td>Openness</td><td>0.193</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>-0.112</td><td>1e-6</td></tr>
<tr><td>Conscientiousness</td><td>-0.233</td><td>&lt;1e-7</td></tr>
</table>

<p>Nicotine users show elevated Neuroticism and strongly reduced Conscientiousness and Agreeableness. Usage patterns vary by country and, to a lesser extent, education.</p>
</details>

<!-- ===================== -->
<!-- AMPHETAMINES -->
<!-- ===================== -->
<details>
<summary><strong>Amphetamines</strong></summary>

<h4>Chi-square</h4>
<table class="mini-table">
<tr><th>Comparison</th><th>Statistic</th></tr>
<tr><td>Education √ó Use</td><td>X¬≤ = 51.73, p = 1.89e-08</td></tr>
<tr><td>Country √ó Use</td><td>X¬≤ = 170.78, p &lt; 2.2e-16</td></tr>
</table>

<h4>ANOVA</h4>
<table class="mini-table">
<tr><th>Trait</th><th>Effect</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>Higher</td><td>6e-06</td></tr>
<tr><td>Extraversion</td><td>No effect</td><td>0.067</td></tr>
<tr><td>Openness</td><td>Higher</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>Lower</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>Lower</td><td>&lt;1e-7</td></tr>
</table>

<h4>Correlations</h4>
<table class="mini-table">
<tr><th>Trait</th><th>r</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>0.133</td><td>&lt;1e-7</td></tr>
<tr><td>Openness</td><td>0.223</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>-0.150</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>-0.239</td><td>&lt;1e-7</td></tr>
</table>

<p>Amphetamine users show one of the most distinctive psychological signatures, marked by high Openness and low Agreeableness and Conscientiousness.</p>
</details>

<!-- ===================== -->
<!-- BENZODIAZEPINES -->
<!-- ===================== -->
<details>
<summary><strong>Benzodiazepines</strong></summary>

<h4>Chi-square</h4>
<table class="mini-table">
<tr><th>Comparison</th><th>Statistic</th></tr>
<tr><td>Education √ó Use</td><td>X¬≤ = 41.59, p = 1.6e-06</td></tr>
<tr><td>Country √ó Use</td><td>X¬≤ = 214.19, p &lt; 2.2e-16</td></tr>
</table>

<h4>ANOVA</h4>
<table class="mini-table">
<tr><th>Trait</th><th>Effect</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>Much higher</td><td>&lt;1e-7</td></tr>
<tr><td>Extraversion</td><td>Lower</td><td>1.4e-04</td></tr>
<tr><td>Openness</td><td>Higher</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>Lower</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>Lower</td><td>&lt;1e-7</td></tr>
</table>

<h4>Correlations</h4>
<table class="mini-table">
<tr><th>Trait</th><th>r</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>0.272</td><td>&lt;1e-7</td></tr>
<tr><td>Extraversion</td><td>-0.104</td><td>6.6e-06</td></tr>
<tr><td>Openness</td><td>0.201</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>-0.166</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>-0.208</td><td>&lt;1e-7</td></tr>
</table>

<p>Benzodiazepine users show dramatic increases in Neuroticism along with some of the lowest Agreeableness/Conscientiousness levels observed across all drug groups.</p>
</details>

<!-- ===================== -->
<!-- STIMULANTS -->
<!-- ===================== -->
<details>
<summary><strong>Stimulants (Cocaine + Methamphetamine)</strong></summary>

<h4>Chi-square</h4>
<table class="mini-table">
<tr><th>Comparison</th><th>Statistic</th></tr>
<tr><td>Education √ó Use</td><td>X¬≤ = 63.87, p = 8.1e-11</td></tr>
<tr><td>Country √ó Use</td><td>X¬≤ = 252.61, p &lt; 2.2e-16</td></tr>
</table>

<h4>ANOVA</h4>
<table class="mini-table">
<tr><th>Trait</th><th>Effect</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>Higher</td><td>&lt;1e-7</td></tr>
<tr><td>Extraversion</td><td>Lower</td><td>0.026</td></tr>
<tr><td>Openness</td><td>Higher</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>Lower</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>Lower</td><td>&lt;1e-7</td></tr>
</table>

<h4>Correlations</h4>
<table class="mini-table">
<tr><th>Trait</th><th>r</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>0.199</td><td>&lt;1e-7</td></tr>
<tr><td>Extraversion</td><td>-0.060</td><td>0.0094</td></tr>
<tr><td>Openness</td><td>0.220</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>-0.216</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>-0.236</td><td>&lt;1e-7</td></tr>
</table>

<p>Stimulant users show a strong externalizing-risk profile: very low Agreeableness/Conscientiousness, elevated Neuroticism, and high Openness.</p>
</details>

<!-- ===================== -->
<!-- HIGH RISK -->
<!-- ===================== -->
<details>
<summary><strong>High-Risk Drugs (Heroin + Crack + VSA)</strong></summary>

<h4>Chi-square</h4>
<table class="mini-table">
<tr><th>Comparison</th><th>Statistic</th></tr>
<tr><td>Education √ó Use</td><td>X¬≤ = 82.25, p = 1.7e-14</td></tr>
<tr><td>Country √ó Use</td><td>X¬≤ = 230.13, p &lt; 2.2e-16</td></tr>
</table>

<h4>ANOVA</h4>
<table class="mini-table">
<tr><th>Trait</th><th>Effect</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>Higher</td><td>&lt;1e-7</td></tr>
<tr><td>Extraversion</td><td>Lower</td><td>7.8e-05</td></tr>
<tr><td>Openness</td><td>Higher</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>Lower</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>Lower</td><td>&lt;1e-7</td></tr>
</table>

<h4>Correlations</h4>
<table class="mini-table">
<tr><th>Trait</th><th>r</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>0.181</td><td>&lt;1e-7</td></tr>
<tr><td>Extraversion</td><td>-0.076</td><td>0.00094</td></tr>
<tr><td>Openness</td><td>0.173</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>-0.173</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>-0.202</td><td>&lt;1e-7</td></tr>
</table>

<p>High-risk substance users show the most extreme personality differences: extremely elevated Neuroticism and the lowest Agreeableness/Conscientiousness scores across all drug groups.</p>
</details>

<!-- ===================== -->
<!-- PSYCHEDELICS -->
<!-- ===================== -->
<details>
<summary><strong>Psychedelics (LSD + Mushrooms + Ketamine + Ecstasy + Legal-H)</strong></summary>

<h4>Chi-square</h4>
<table class="mini-table">
<tr><th>Comparison</th><th>Statistic</th></tr>
<tr><td>Education √ó Use</td><td>X¬≤ = 187.32, p &lt; 2.2e-16</td></tr>
<tr><td>Country √ó Use</td><td>X¬≤ = 410.56, p &lt; 2.2e-16</td></tr>
</table>

<h4>ANOVA</h4>
<table class="mini-table">
<tr><th>Trait</th><th>Effect</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>Higher</td><td>1.5e-06</td></tr>
<tr><td>Extraversion</td><td>No effect</td><td>0.065</td></tr>
<tr><td>Openness</td><td>Extremely higher</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>Lower</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>Lower</td><td>&lt;1e-7</td></tr>
</table>

<h4>Correlations</h4>
<table class="mini-table">
<tr><th>Trait</th><th>r</th><th>p</th></tr>
<tr><td>Neuroticism</td><td>0.087</td><td>0.00016</td></tr>
<tr><td>Extraversion</td><td>0.020</td><td>0.378</td></tr>
<tr><td>Openness</td><td>0.397</td><td>&lt;1e-7</td></tr>
<tr><td>Agreeableness</td><td>-0.150</td><td>&lt;1e-7</td></tr>
<tr><td>Conscientiousness</td><td>-0.258</td><td>&lt;1e-7</td></tr>
</table>

<p>Psychedelic users are characterized primarily by high Openness. Education and country strongly influence prevalence.</p>
</details>

<h2>Interpretation</h2>
<p>
Across all analyses, a consistent pattern emerged linking personality traits with patterns of drug use.
</p>

<h3>1. Core Personality Traits Predict Substance Use</h3>
<p>
Across nearly all drug categories, four traits showed the strongest and most consistent associations:
</p>

<ul>
  <li><strong>Openness</strong> ‚Äì the strongest positive predictor of both trying and frequently using substances. Users scored significantly higher across cannabis, nicotine, amphetamines, benzodiazepines, stimulants, and psychedelics.</li>
  <li><strong>Neuroticism</strong> ‚Äì elevated among users of most drug categories, especially stimulants, benzodiazepines, and high-risk drugs. Higher usage frequency was also positively correlated with neuroticism.</li>
  <li><strong>Agreeableness</strong> ‚Äì consistently lower among users, indicating less compliance, cooperativeness, and prosocial behavior.</li>
  <li><strong>Conscientiousness</strong> ‚Äì strongly negatively associated with all forms of drug use, reflecting reduced impulse control and lower behavioral regulation.</li>
</ul>

<p>
Extraversion showed the weakest and least consistent effects, aligning with findings from previous literature.
</p>

<h3>2. Legal vs. Illegal Substances Show Distinct Usage Patterns</h3>
<p>
Chi-squared tests and exploratory visualizations revealed sharp differences between legal and illegal substances:
</p>
<ul>
  <li><strong>Legal drugs</strong> (alcohol, nicotine) had higher consumption levels overall and higher frequencies in the medium-to-heavy range.</li>
  <li><strong>Illegal drugs</strong> (cannabis, stimulants, psychedelics, high-risk opioids) showed high proportions of users in the low-frequency range, suggesting sporadic experimentation.</li>
</ul>

<p>
This pattern likely reflects <em>availability, cultural norms, perceived risk, and legal access</em>.
</p>

<h3>3. Stimulants (Cocaine + Meth) Show a Distinctive Personality Profile</h3>
<p>
The combined stimulant group demonstrated some of the strongest personality effects:
</p>
<ul>
  <li>Higher <strong>Neuroticism</strong></li>
  <li>Lower <strong>Agreeableness</strong> and <strong>Conscientiousness</strong></li>
  <li>Moderate increases in <strong>Openness</strong></li>
</ul>
<p>
These results align with established psychological risk profiles for stimulant misuse, particularly impulsivity and emotional dysregulation.
</p>

<h3>4. Psychedelic Use Is Most Strongly Linked to Openness</h3>
<p>
Psychedelic users (LSD, mushrooms, ketamine, ecstasy, legal highs) showed:
</p>
<ul>
  <li>Large positive effects on <strong>Openness</strong></li>
  <li>Moderately lower <strong>Agreeableness</strong> and <strong>Conscientiousness</strong></li>
  <li>Minimal involvement of <strong>Extraversion</strong></li>
</ul>

<p>
This suggests that curiosity, novelty-seeking, and cognitive exploration are major drivers of psychedelic experimentation.
</p>

<h3>5. High-Risk Drug Use (Heroin, Crack, VSA)</h3>
<p>
Although relatively rare in the dataset, users of high-risk drugs exhibited:
</p>
<ul>
  <li>Strongly elevated <strong>Neuroticism</strong></li>
  <li>Markedly lower <strong>Agreeableness</strong> and <strong>Conscientiousness</strong></li>
</ul>

<p>
This reflects known clinical patterns: reduced impulse control, emotional instability, and high behavioral risk-taking.
</p>

<h3>6. Overall Synthesis</h3>
<p>
Across all drug categories and statistical methods, three overarching themes emerged:
</p>
<ul>
  <li><strong>Openness</strong> predicts <em>trying more types of substances</em>.</li>
  <li><strong>Neuroticism</strong> predicts <em>more frequent or heavier use</em>.</li>
  <li><strong>Agreeableness</strong> and <strong>Conscientiousness</strong> protect against use across nearly all substances.</li>
</ul>

<p>
Combined with the influence of education and country-level factors, these results suggest that personality traits and sociocultural context jointly shape patterns of drug experimentation and use. While causation cannot be inferred, the consistency of patterns across multiple substances underscores the stability of these psychological profiles.
</p>

  <p>
    üëâ For the full R Markdown workflow establishing all inferential analyses,
    including the chi-square tests, ANOVAs, and correlation models, see:
    <a href="inferential_analyses.html" target="_blank" rel="noopener noreferrer">
      <strong>Detailed Statistical Output</strong>
    </a>.
  </p>
</section>

<p style="margin-top: 2rem; font-size: 1.1rem;">
  üëâ For the complete write-up, including data cleaning, visualization details, and full inferential models, see:
  <a href="final_report.html" 
     target="_blank" 
     rel="noopener noreferrer"
     style="text-decoration: underline; font-weight: 600;">
     Final Report
  </a>
</p>

</main>

<footer class="site-footer">
  <p><a href="index.html">‚Üê Back to Home</a></p>
</footer>

<script src="script.js?v=1" defer></script>

</body>
</html>
